Medications for Metastatic Merkel Cell Carcinoma

2 results

  • bavencio

    (avelumab)
    EMD Serono, Inc.
    BAVENCIO (avelumab) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma, maintenance treatment of locally advanced or metastatic urothelial carcinoma after platinum chemotherapy, and first-line treatment of advanced renal cell carcinoma in combination with axitinib.

  • zynyz

    (retifanlimab-dlwr)
    Incyte Corporation
    ZYNYZ is indicated for treating adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Its accelerated approval is based on tumor response rates, with ongoing approval dependent on confirming clinical benefits in further trials.